{
    "address": "",
    "city": "Lund",
    "country": "SE",
    "currency": "",
    "cusip": "W7S50Z135",
    "description": "Pharmiva AB (publ) is a Sweden-based medical technology company within FemTech that is focused on research and development of medical products. The company is headquartered in Lund, Skane. The company went IPO on 2021-03-31. Pharmiva AB (publ) aims to improve vaginal health and reduce the risk of complications by offering treatments without antibiotics. The firm's first product Vernivia is antibiotic- and prescription-free treatment for bacterial vaginosis (BV). The treatment is based on Pharmiva AB's (publ) patented drug delivery platform, Venerol, which contains naturally occurring ingredients. The firm has received CE marking class IIa for Vernivia, which means that Pharmiva AB (publ) has the right to sell and market the product within the EEA. Pharmiva AB (publ) is also ISO-certified according to ISO 13485 current design, production, marketing and sales.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "N/A",
    "ggroup": "N/A",
    "gind": "N/A",
    "gsector": "N/A",
    "gsubind": "N/A",
    "ipo": "2021-03-31",
    "isin": "SE0015530670",
    "logo": "",
    "marketCapitalization": 69.21,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Biological Product (except Diagnostic) Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Pharmiva AB (publ)",
    "phone": "46462865100.0",
    "sedol": "BMVN4T8",
    "shareOutstanding": 7.14,
    "state": "SKANE",
    "ticker": "PHARM.ST",
    "weburl": ""
}